Spots Global Cancer Trial Database for progesterone receptor
Every month we try and update this database with for progesterone receptor cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Endometrial Tissues and Mononuclear Cells Receptivity in Pathogenesis of Endometrial Proliferative Processes | NCT06115577 | Endometrial Hyp... Endometrial Hyp... Endometrial Can... Peripheral Bloo... Postmenopause Estrogen Recept... Progesterone Re... | endometrial tis... | 53 Years - 80 Years | Pirogov Russian National Research Medical University | |
| Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy | NCT02449993 | Breast Cancer | MammaTyper™ | 18 Years - 70 Years | BioNTech Diagnostics GmbH | |
| Study Assessing Efficacy of ZARNESTRA™ Combined With Tamoxifen in Patients With Advanced or Metastatic Breast Cancer | NCT00210028 | Breast Neoplasm... | Tamoxifen Zarnestra | 18 Years - | Institut Claudius Regaud | |
| A Pharmacokinetic and Randomized Trial of Neoadjuvant Treatment With Anastrozole Plus AZD0530 in Postmenopausal Patients With Hormone Receptor Positive Breast Cancer | NCT01216176 | Breast Cancer | Anastrozole AZD0530 (saraca... Placebo | 18 Years - | University of Miami | |
| Effect of Fertility-sparing Therapy of Early Endometrial Cancer | NCT03538704 | Endometrial Can... Fertility | Metformin | 18 Years - 40 Years | Peking University People's Hospital | |
| PALbociclib Rechallenge in horMone Receptor-posItive/HER2- Negative Advanced Breast Cancer (PALMIRA) | NCT03809988 | Breast Cancer Advanced Breast... Hormone Recepto... Human Epidermal... | Palbociclib Endocrine thera... | 18 Years - | MedSIR | |
| 18-F-Fluoroacetate as PET Imaging Agent | NCT01320787 | Brain Cancer Breast Cancer Prostate Cancer | 18F-fluoroaceta... | 18 Years - | M.D. Anderson Cancer Center | |
| Hormone Receptor Positive Disease Across Solid Tumor Types: A Phase I Study of Single-Agent Hormone Blockade and Combination Approaches With Targeted Agents to Provide Synergy and Overcome Resistance | NCT01197170 | Solid Tumors Advanced Cancer | Anastrozole Bevacizumab Everolimus Sorafenib Erlotinib | 18 Years - | M.D. Anderson Cancer Center | |
| Re-Examination of Tumor Material and Re-Evaluation of Patient Data From Patients Treated With Neo-adjuvant Therapy | NCT02449993 | Breast Cancer | MammaTyper™ | 18 Years - 70 Years | BioNTech Diagnostics GmbH | |
| Neoadjuvant Endocrine Therapy in Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2 (HER2)-Negative Node-Negative Breast Cancer | NCT03219476 | Breast Cancer Invasive Breast... | Anastrozole Letrozole Exemestane Tamoxifen | 18 Years - | Medical College of Wisconsin | |
| Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression | NCT03870399 | Neuroendocrine ... Progesterone Re... Estrogen Recept... | Tamoxifen | 18 Years - | AC Camargo Cancer Center | |
| Effect of Fertility-sparing Therapy of Early Endometrial Cancer | NCT03538704 | Endometrial Can... Fertility | Metformin | 18 Years - 40 Years | Peking University People's Hospital | |
| Study of Tamoxifen in Well Differentiated Neuroendocrine Tumors and Hormone Receptor Positive Expression | NCT03870399 | Neuroendocrine ... Progesterone Re... Estrogen Recept... | Tamoxifen | 18 Years - | AC Camargo Cancer Center |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
